Auryis Lifesciences – QI is a regulatory-grade AI compliance platform built for pharmaceutical and life sciences organizations. It brings together advanced AI and domain expertise to deliver continuous audit readiness, faster validation, and stronger quality assurance — eliminating manual, reactive processes.
At its core, Auryis QI leverages Pharma-specific intelligence to understand regulatory intent, automate complex validation processes, and provide end-to-end traceability across the compliance lifecycle. By shifting from manual, reactive workflows to a proactive, intelligence-driven approach, it empowers organizations to identify risks early, ensure consistency, and maintain audit-ready operations at all times.
With Auryis QI, quality is no longer a checkpoint — it becomes a continuous, scalable, and strategic capability that drives efficiency, reduces risk, and accelerates time-to-market.
Break free from manual, reactive processes. Auryis QI uses domain-trained AI to accelerate validation, eliminate inefficiencies, and surface risks before regulators do — so you stay audit-ready, always.
Accelerate validation with automated analysis and gap detection — freeing QA teams for high-value decisions.
Move from reactive audits to continuous compliance with real-time readiness across products and sites.
Identify and resolve compliance gaps early with predictive pre-audit insights — before findings escalate.
Standardize regulatory processes across products, sites, and teams — eliminating variability in execution.
Minimize manual review work, enabling experts to focus on validation and critical decisions.
Quality becomes a continuous, scalable, and strategic capability — driving efficiency and reducing risk.
Six purpose-built capabilities that convert regulatory complexity into a clear, traceable, and explainable workflow — from intent to evidence.
Regulatory-trained AI delivering precise, explainable insights tuned to pharma intent.
Applies contextual logic across documents for accurate, repeatable compliance evaluation.
Links requirements, specifications, tests, and evidence seamlessly across the compliance lifecycle.
Predicts risks early to prevent audit findings before they become formal observations.
AI plus expert validation — working together for accurate, auditable outcomes.
Built-in PII masking and role-aware access for safe, compliant data handling at scale.
Traceable, explainable, and audit-compliant by design — no rework before submission.
A structured, consultative journey designed to demonstrate measurable value at every stage — from first contact through to enterprise deployment and ongoing partnership.
We start by understanding your regulatory landscape, current quality posture, and the most painful gaps in your validation and audit workflows. The goal: a shared view of where Auryis QI moves the needle.
A tailored demonstration of Auryis QI against your real-world scenarios. We showcase how the platform handles your documents, regulations, and validation rules — proving fit before you commit.
A time-boxed pilot where Auryis QI runs against a real workload from your environment. We measure the impact — speed, accuracy, SME hours saved — so the business case writes itself.
Enterprise deployment with white-glove onboarding, then a long-term partnership focused on continuous improvement, expansion to new use-cases, and quarterly value reviews.
“We map every conversation to a regulatory outcome — so nothing in your audit cycle gets left to chance.”
“You see Auryis QI handle your real documents, your real regulations — not a canned demo script.”
“Decisions are made on data from your environment — the business case writes itself.”
“Deployment is the start, not the end. We grow with you, use-case by use-case.”
Auryis QI is purpose-built for organizations where compliance is non-negotiable — starting with the most regulated corner of the world: life sciences.
Auryis QI is engineered around the validation, audit, and quality workflows that define modern pharma. From IND through commercial release — accelerate every stage without compromising regulatory rigor.
Bring novel therapies to market faster with regulatory-grade quality intelligence tuned for biologics and advanced therapeutics.
Standardize design controls and traceability across products, sites, and teams.
Enforce protocol integrity, automate review, and reduce SME time across trials.
Maintain consistent compliance across multi-site, multi-client CDMO operations.
Ensure continuous quality assurance with predictive risk insights at the point of care.
Models grounded in pharma regulatory frameworks, not generic LLMs
Move from reactive audits to real-time, always-on compliance
Every engagement tied to measurable QA and audit-readiness KPIs
PII masking and role-aware access for safe, compliant data handling
30+ years of regulated-industry delivery across pharma, BFSI, and healthcare
Whether you’re modernizing validation, automating audits, or scaling quality across global sites — Auryis is built to make compliance simple, predictive, and continuous.